UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000041095
Receipt No. R000046933
Scientific Title Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Date of disclosure of the study information 2020/07/13
Last modified on 2020/07/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Acronym Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Scientific Title Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists
Scientific Title:Acronym Relationship between beta-adrenergic receptor agonists and ureteral stones
Region
Japan

Condition
Condition Ureteral stones
Classification by specialty
Surgery in general Urology Emergency medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the clinical effects of beta-adrenergic receptor agonists on the treatment of ureteral stones
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Complete fracture rate of ureteral stones, postoperative recurrence rate, HU value
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
10 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria All patients treated with ureteral stones at Showa University Fujigaoka Hospital
Key exclusion criteria (1) Patients under 10 years old
(2) Patients who do not get written consent
(3) Patients who cannot be examined by CT
(4) Patients scheduled to be treated in another hospital
(5) Patients who are judged to be inappropriate by other researchers
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Yuki
Middle name
Last name Matusi
Organization Showa University Fujigaoka Hospital
Division name Urology Department
Zip code 227-8501
Address 1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
TEL 045-971-1151
Email hyperzector555@med.showa-u.ac.jp

Public contact
Name of contact person
1st name Yuki
Middle name
Last name Matsui
Organization Showa University Fujigaoka Hospital
Division name Urology Department
Zip code 227-8501
Address 1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
TEL 045-971-1151
Homepage URL
Email hyperzector555@med.showa-u.ac.jp

Sponsor
Institute Showa University Fujigaoka Hospital
Institute
Department

Funding Source
Organization Showa University Fujigaoka Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Showa University Fujigaoka Hospital Clinical Study Review Board
Address 1-30 Fujigaoka Aoba-ku Yokohama Kanagawa Japan
Tel 045-971-1151
Email hyperzector555@med.showa-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 07 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 12 Month 01 Day
Date of IRB
2019 Year 12 Month 18 Day
Anticipated trial start date
2019 Year 12 Month 19 Day
Last follow-up date
2026 Year 04 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Regarding the treatment of ureteral stones at Showa University Fujigaoka Hospital, we will investigate the effect of beta-adrenergic receptor stimulants and perform statistical analysis.

Management information
Registered date
2020 Year 07 Month 13 Day
Last modified on
2020 Year 07 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046933

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.